StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AMH2-B.ST$59.50+0.00%
Fair $59.50+0.0%

AMH2-B.ST

Amhult 2 AB (publ)

Real Estate / Real Estate - DiversifiedStockholm

$59.50

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $59.50Fund rank 28/100 · Data gapFallback financials|
SA 31/D
F-Score: 5/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 17.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 32/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

31/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific NAV/AFFO model required: REIT/real-estate targets are disabled until FFO/AFFO/NAV/cap-rate data exists. REIT NAV/AFFO valuation requires positive AFFO/share history or TTM AFFO/share; generic FCF remains disabled. ROE is 4.3%, below the 5% threshold
Thesis & Journal · AMH2-B.STLocal privado en este navegador · Amhult 2 AB (publ)
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$407M

P/E

10.5x

↓

EV/EBITDA

15.4x

↑

ROE

4.3%

↓

Gross Margin

82.8%

↑

Debt/Equity

1.05

↑
52-Week Range$60
$56$65

TradingView lightweight chart

AMH2-B.ST price, volumen y niveles de valoración

Último $59.00Periodo +216.1%
Fair value: $59.50

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+10.3%

FCF CAGR

-48.5%

FCF margin

5.0%

FCF / Net income

0.14x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $103.8M · net income $37.5M · FCF $5.2M

2022-FY → 2025-FY

Gross margin

82.8%+3.4% pts

Operating margin

71.8%+2.9% pts

Net margin

36.2%+34.5% pts

FCF margin

5.0%-44.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$103.8M$103.8M$93.7M$82.7M$77.3M
Net Income$37.5M$37.5M$77.7M$30.8M$1.3M
EBITDA$85.6M$85.6M$145.6M$68.1M$14.2M
EPS——11.344.490.19
Gross Margin82.8%82.8%81.9%79.8%79.4%
Operating Margin71.8%71.8%70.6%69.1%68.9%
Net Margin36.2%36.2%82.9%37.2%1.7%
Balance Sheet
Debt/Equity1.051.051.111.121.00
Current Ratio0.280.28———
Cash Flow
Free Cash Flow$5.2M$5.2M$-90.9M$44.2M$37.8M
Returns
ROE4.3%4.3%9.3%4.1%0.2%
Valuation
P/E10.4610.465.1112.36347.37
EV/EBITDA15.3515.358.9917.6381.78
P/B0.470.470.480.500.62
Growth & Yield
Revenue Growth10.8%10.8%13.3%7.0%—
EPS Growth——152.6%2263.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +1.7%

Total return

+1.7%

Start / end P/E

n/dx → n/dx

EPS bridge

11.34 → n/d

Residual

+1.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+1.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.